Skip to main content
SpringerLink
Log in

Current Approaches to the Prophylaxis of Migraine

  • Practical Therapeutics
  • Published:
CNS Drugs Aims and scope Submit manuscript

Summary

Migraine is a prevalent and often debilitating condition. Because of this, effective prophylaxis to prevent the recurrence of attacks is an advantageous approach to therapy for some patients.

Five main classes of prophylactic agents are currently employed: β-blockers, calcium antagonists, serotonin (5-hydroxytryptamine; 5-HT) modulators, non-steroidal anti-inflammatory drugs and ergot alkaloids. Many variables influence the choice of therapy, including the different characteristics of the available drugs and of each patient. Although β-blockers and flunarizine are generally the most effective prophylactic agents, there is no drug of first-choice and the agent chosen must be carefully tailored to the needs of the individual patient.

Status migrainosus — prolonged unresponsive migraine attacks — requires, in most patients, a specific administration protocol consisting of dihydroergot-amine, steroids and phenothiazines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8: 1–97

    Article  Google Scholar 

  2. Rasmussen BK, Jensen R, Schroll M, et al. Epidemiology of headache in a general population — a prevalence study. J Clin Epidemiol 1991; 11: 1147–57

    Article  Google Scholar 

  3. Osterhaus KT, Gutterman DL, Plachetka JR. Healthcare resource and lost labour costs of migraine headache in the US. PharmacoEconomics 1992; 2: 67–76

    Article  PubMed  CAS  Google Scholar 

  4. Goadsby PJ. Diagnosis and optimum treatment of migraine. CNS Drugs 1994; 1: 245–53

    Article  Google Scholar 

  5. Selby G, Lance JW. Observation on 500 cases of migraine and allied vascular headaches. J Neurol Neurosurg Psychiatry 1960; 23: 23–32

    Article  PubMed  CAS  Google Scholar 

  6. Kangasheimi P, Andersen AR, Andersson PG, et al. Classic migraine: effective prophylaxis with metoprolol. Cephalalgia 1987; 7: 231–8

    Article  Google Scholar 

  7. Lauritzen M, Skyhoj Olsen T, Lassen NA, et al. The changes of regional cerebral blood flow during the course of classical migraine attacks. Ann Neurol 1983; 13: 633–41

    Article  PubMed  CAS  Google Scholar 

  8. Olesen J, Tfelt-Hansen P, Henriksen L, et al. The common migraine attack may not be initiated by cerebral ischaemia. Lancet 1981; 2: 438–40

    Article  PubMed  CAS  Google Scholar 

  9. Welch KMA, Levine SR. Migraine-related stroke in the context of the International Headache Society classification of head pain. Arch Neurol 1990; 47: 458–62

    Article  PubMed  CAS  Google Scholar 

  10. Sicuteri F. Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine. Int Arch Allerg 1959; 15: 300–7

    Article  PubMed  CAS  Google Scholar 

  11. Rabkin R, Stables DP, Levin NW, et al. The prophylactic value of propranolol in angina pectoris. Am J Cardiol 1966; 18: 370–83

    Article  PubMed  CAS  Google Scholar 

  12. Drillisch C, Girke W. Ergebnisse der behandlung von migran patienten it cinnarizin und fluarizin. Med Welt 1980; 31: 1870–2

    PubMed  CAS  Google Scholar 

  13. Nappi G, Manzoni GC. Manuale delle cefalee. Milano: Cluster Press, 1991: 152–230

    Google Scholar 

  14. Tfelt-Hansen P. Efficacy of beta-blockers in migraine: a critical review. Cephalalgia 1986; 6 Suppl. 5: 15–24

    PubMed  Google Scholar 

  15. Venter CP, Joubert PH, Buys AC. Severe peripheral ischaemia during concomitant use of beta blockers and ergot alkaloids. BMJ 1984; 289: 288–9

    Article  PubMed  CAS  Google Scholar 

  16. Andersson P-G, Dahl S, Hansen JH, et al. Prophylactic treatment of classical and non-classical migraine with metoprolol — a comparison with placebo. Cephalalgia 1983; 3: 207–12

    Article  PubMed  CAS  Google Scholar 

  17. Forssman B, Lindblad CJ, Zbornikova V. Atenolol for migraine. Headache 1983; 23: 188–90

    Article  PubMed  CAS  Google Scholar 

  18. Briggs RS, Millac PA. Timolol in migraine prophylaxis. Headache 1979; 19: 379–81

    Article  PubMed  CAS  Google Scholar 

  19. Ryan Sr RE, Ryan Jr RE, Sudilovsky A. Nadolol: its use in the prophylactic treatment of migraine. Headache 1983; 23: 26–31

    Article  PubMed  Google Scholar 

  20. Agnoli A. The classification of calcium antagonists by the WHO expert committee: relevance in neurology. Cephalalgia 1988; 8 Suppl. 8: 7–10

    PubMed  Google Scholar 

  21. Andersson K-E, Vinge E. Beta-adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine. Drugs 1990; 39: 355–73

    Article  PubMed  CAS  Google Scholar 

  22. Leone M, Grazzi L, La Mantia L, et al. Flunarizine in migraine: aminireview. Headache 1991; 31: 388–91

    Article  PubMed  CAS  Google Scholar 

  23. Todd PA, Benfield P. Flunarizine: a reappraisal of its pharmacological properties and therapeutic use in neurological disorders. Drugs 1989; 38: 481–99

    Article  PubMed  CAS  Google Scholar 

  24. Manzoni GC, Bussone G, Granella F, et al. Long-term efficacy and safety of flunarizine in the prophylaxis of migraine without aura. Cephalalgia 1989; 9 Suppl. 10: 426–7

    Google Scholar 

  25. Bono G, Manoni GC, Martucci N, et al. Flunarizine in common migraine: Italian cooperative trial, II. Long term follow-up. Cephalalgia 1985; Suppl. 2: 155–8

    Google Scholar 

  26. Sorge F, De Simone R, Marano R, et al. Flunarizine in prophylaxis of childhood migraine. Cephalalgia 1988; 8: 1–6

    Article  PubMed  CAS  Google Scholar 

  27. Riopelle RJ, McCans JL. A pilot study of the calcium antagonists diltiazem in migraine syndrome prophylaxis [abstract]. J Can Sci Neurol 1982; 9: 269

    Google Scholar 

  28. Leone M, Frediani F, Patruno G, et al. Is nimodipine useful in migraine prophylaxis?. Headache 1990; 30: 363–5

    Article  PubMed  CAS  Google Scholar 

  29. Solomon GD, Steel JG, Spaccavento LJ. Verapamil prophylaxis of migraine: a doubleblind placebo-controlled trial. JAMA 1983; 250: 2500–2

    Article  PubMed  CAS  Google Scholar 

  30. Bussone G, Leone M, Peccarisi C, et al. Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache 1990; 30: 411–7

    Article  PubMed  CAS  Google Scholar 

  31. Mylecharane EJ. 5-HT receptor antagonists and migraine therapy. J Neurol 1991; 238: S45–52

    Article  PubMed  Google Scholar 

  32. Speight TM, Avery GS. Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches. Drugs 1972; 3: 159–203

    Article  PubMed  CAS  Google Scholar 

  33. Couch JR, Hassanein R. Amitriptyline in migraine prophylaxis. Arch Neurol 1979; 36: 695–9

    Article  PubMed  CAS  Google Scholar 

  34. Stensrud P, Sjaastad O. Clinical trial of a new anti-bradykinin, anti-inflammatory drug, ketoprofen in migraine prophylaxis. Headache 1974; 14: 96–100

    Article  PubMed  CAS  Google Scholar 

  35. Mikkelsen BM, Falk JV. Prophylactic treatment of migraine with tolfenamic acid. A comparative double-blind crossover study between tolfenamic acid and placebo. Acta Neurol Scand 1982; 66: 105–11

    Article  PubMed  CAS  Google Scholar 

  36. Welch KMA, Ellis DA, Keenan PA. Successful migraine prophylaxis with naproxen sodium. Neurology 1985; 35; 1304–10

    Article  PubMed  CAS  Google Scholar 

  37. Facchinetti F, Fioroni L, Sances G, et al. Naproxene sodium in the treatment of premenstrual symptoms: a placebo controlled study. Gynecol Obsted Invest 1989; 28: 205–8

    Article  CAS  Google Scholar 

  38. O’Neill BP, Mann JD. Aspirin prophylaxis in migraine. Lancet 1978; ii: 1179–81

    Article  Google Scholar 

  39. Pradalier A, Clapin A, Dry J. Treatment review: non-steroid antiinflammatory drugs in the treatment and long-term prevention of migraine attacks. Headache 1988; 28: 550–7

    Article  PubMed  CAS  Google Scholar 

  40. Moskowitz MA. The neurobiology of vascular headache pain. Ann Neurol 1984; 16: 156–68

    Article  Google Scholar 

  41. Hosman-Benjaminse SL, Bolhius PA. Migraine and platelet aggregation in patients treated with low dose acetylsalicylic acid. Headache 1986; 26: 282–4

    Article  PubMed  CAS  Google Scholar 

  42. Pradalier A, Vincent D. Migraine et anti-inflammatories non-steroidiens. Pathol Biol (Paris) 1992; 40: 397–405

    CAS  Google Scholar 

  43. Scott AK. Dihydroergotamine: a review of its use in the treatment of migraine and other headaches. Clin Neuropharmacol 1992; 15: 289–96

    Article  PubMed  CAS  Google Scholar 

  44. Frediani F, Grazzi L, Zanotti A, et al. Dihydroergocryptine versus dihydroergotamine in migraine prophylaxis: a double-blind clinical trial. Cephalalgia 1991; 11: 117–21

    Article  PubMed  CAS  Google Scholar 

  45. Whitty CWM, Hockaday JM, Witty MM. The effect of oral contraceptives on migraine. Lancet 1966; 1: 856–9

    Article  PubMed  CAS  Google Scholar 

  46. Larsson-Cohn U, Lundberg PO. Headache and treatment with oral contraceptives. Acta Neurol Scand 1970; 46: 267–78

    Article  PubMed  CAS  Google Scholar 

  47. Hering R, Kuritzky A. Sodium valproate in the prophylactic treatment of migraine: a double blind study versus placebo. Cephalalgia 1992; 12: 81–4

    Article  PubMed  CAS  Google Scholar 

  48. Sorensen KV. Valproate: a new drug in migraine prophylaxis. Acta Neurol Scand 1988; 78: 346–8

    Article  PubMed  CAS  Google Scholar 

  49. Welch KMA. Drug therapy of migraine. N Engl J Med 1993; 329: 1476–83

    Article  PubMed  CAS  Google Scholar 

  50. Raskin NH. Treatment of status migrainosus: the American experience. Headache 1990; 30 Suppl. 2: 550–3

    Article  PubMed  Google Scholar 

  51. Gallagher MR. Emergency treatment of intractable migraine. Headache 1986; 26: 74–5

    Article  PubMed  CAS  Google Scholar 

  52. Lane PL, Ross R. Intravenous chlorpromazine — preliminary results in acute migraine. Headache 1985; 25: 302–4

    Article  PubMed  CAS  Google Scholar 

  53. Jones J, Sklar D, Dougherty J, et al. Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache. JAMA 1989; 261: 1174–85

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Headache Centre, Istituto Neurologico ‘Carlo Besta’, via Celoria 11, 20133, Milan, Italy

    Massimo Leone &  Gennaro Bussone

Authors
  1. Massimo Leone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gennaro Bussone
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leone, M., Bussone, G. Current Approaches to the Prophylaxis of Migraine. CNS Drugs 3, 165–173 (1995). https://doi.org/10.2165/00023210-199503030-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-199503030-00002

Keywords

Search

Navigation